ReviewNature methods2026
From pixels to patterns: the AI revolution in stem cell-derived models.
Review in Nature methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Embedding AI in biology - part 2.Nature methods · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Artificial intelligence (AI) is rapidly transforming stem cell and developmental biology, offering new strategies to analyze, interpret and optimize complex, dynamic systems such as organoids and stem cell-derived embryo models. In this Perspective, we chart the integration of AI into image-based analysis of stem cell systems, highlighting how deep learning, convolutional neural networks and emerging foundation models enable automated classification, segmentation and phenotyping at increasing scale and precision. We showcase applications in phenotyping, drug screening and mechanistic discovery, including real-time fate prediction and the identification of hidden morphological signatures linked to differentiation and disease. Practical challenges, including limited annotated data, model interpretability and live imaging constraints, are examined alongside future opportunities, such as multimodal integration, real-time experimental steering and protocol optimization. Altogether, we argue that AI is not merely an analytical tool, but a discovery engine that enhances reproducibility, accelerates insight and brings us closer to a mechanistic understanding of self-organization in complex stem cell-derived systems.
Indexed as
Identifiers
42601460What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.